GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Capex-to-Revenue

American Vietnamese Biotech (HSTC:AMV) Capex-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

American Vietnamese Biotech's Capital Expenditure for the three months ended in . 20 was ₫0.00 Mil. Its Revenue for the three months ended in . 20 was ₫0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


American Vietnamese Biotech Capex-to-Revenue Historical Data

The historical data trend for American Vietnamese Biotech's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Capex-to-Revenue Chart

American Vietnamese Biotech Annual Data
Trend
Capex-to-Revenue

American Vietnamese Biotech Quarterly Data
Capex-to-Revenue

Competitive Comparison of American Vietnamese Biotech's Capex-to-Revenue

For the Biotechnology subindustry, American Vietnamese Biotech's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Vietnamese Biotech's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Capex-to-Revenue falls into.



American Vietnamese Biotech Capex-to-Revenue Calculation

American Vietnamese Biotech's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

American Vietnamese Biotech's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Vietnamese Biotech  (HSTC:AMV) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


American Vietnamese Biotech Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


American Vietnamese Biotech (HSTC:AMV) Business Description

Traded in Other Exchanges
N/A
Address
20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.

American Vietnamese Biotech (HSTC:AMV) Headlines

From GuruFocus